BioUtah's 2025 Utah Life Sciences Summit Announces Early Bird Registration with High-Profile Federal Speakers

BioUtah, Utah's trade association for the life sciences community, has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown, offering reduced pricing until October 17. The summit will convene on November 12 at the Hilton Salt Lake City Center, attracting over 500 registrants including life sciences leaders, experts, policymakers, and professionals to discuss industry dynamics, regulatory landscapes, market trends, and innovation strategies.

The significance of this gathering extends beyond networking opportunities, as Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs. This economic impact underscores the summit's importance for maintaining momentum in a sector that drives both state prosperity and healthcare advancement nationwide.

Keynote speakers include prominent federal regulators who will address critical issues affecting the entire life sciences ecosystem. Melissa Holyoak, Commissioner of the Federal Trade Commission, brings expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will conduct a virtual FDA Town Hall discussion about the agency's policy priorities and regulatory initiatives.

Peter Marks, MD, former head of the FDA's Center for Biologics Evaluation and Research, will share insights from overseeing the rapid expansion of FDA-approved cell and gene therapies and his key role in establishing Operation Warp Speed that accelerated COVID-19 vaccine development. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the speaker lineup as a global healthcare thought leader known for creating novel solutions to complex problems.

The summit features dedicated networking programs, including lunchtime sessions designed to facilitate meaningful professional connections. Attendees can access specialized tracks covering workforce development, market access, regulatory and quality compliance, and legal considerations. Register at https://bioutah.org/summit-registration for early bird discounts and view the preliminary agenda at https://bioutah.org/summit-agenda.

Kelvyn Cullimore, president and CEO of BioUtah, emphasized the event's comprehensive nature, stating that whether participants focus on medical device manufacturing, diagnostics, or biopharmaceuticals, they will find relevant and engaging content. The summit will also recognize industry achievements through awards presented to individuals and companies for their valuable contributions to life sciences.

This gathering comes at a crucial time for healthcare innovation, as regulatory frameworks evolve and new technologies emerge. The participation of top FDA officials and FTC leadership signals the importance of regulatory alignment with industry growth, particularly in a state where life sciences have become a cornerstone of economic development and healthcare advancement.